BIOTA PHARMACEUTIALS INC's ticker is BOTA and the CUSIP is 090694100. A total of 50 filers reported holding BIOTA PHARMACEUTIALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $9,000 | -25.0% | 6,248 | 0.0% | 0.00% | – |
| Q4 2015 | $12,000 | +9.1% | 6,248 | +8.9% | 0.00% | – |
| Q3 2015 | $11,000 | -8.3% | 5,738 | 0.0% | 0.00% | – |
| Q2 2015 | $12,000 | -7.7% | 5,738 | 0.0% | 0.00% | – |
| Q1 2015 | $13,000 | 0.0% | 5,738 | 0.0% | 0.00% | – |
| Q4 2014 | $13,000 | -7.1% | 5,738 | 0.0% | 0.00% | – |
| Q3 2014 | $14,000 | -12.5% | 5,738 | +2.6% | 0.00% | – |
| Q2 2014 | $16,000 | – | 5,592 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 3,486,711 | $6,764,000 | 0.42% |
| SENZAR ASSET MANAGEMENT, LLC | 1,910,476 | $3,706,323,000 | 0.41% |
| TOWERVIEW LLC | 160,000 | $310,000 | 0.16% |
| BVF INC/IL | 350,776 | $681,000 | 0.12% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 218,177 | $423,000 | 0.05% |
| EAGLE GLOBAL ADVISORS LLC | 272,072 | $528,000 | 0.02% |
| Spark Investment Management LLC | 70,500 | $136,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 203,170 | $394,000 | 0.01% |
| JW Asset Management, LLC | 8,611 | $17,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 147,281 | $286,000 | 0.01% |